GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » Research & Development

Qilian International Holding Group (Qilian International Holding Group) Research & Development : $0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Qilian International Holding Group's Research & Development for the six months ended in Sep. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.


Qilian International Holding Group Research & Development Historical Data

The historical data trend for Qilian International Holding Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group Research & Development Chart

Qilian International Holding Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Research & Development
Get a 7-Day Free Trial - - - - -

Qilian International Holding Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Qilian International Holding Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qilian International Holding Group  (NAS:QLI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Qilian International Holding Group Research & Development Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Qilian International Holding Group (Qilian International Holding Group) Business Description

Traded in Other Exchanges
N/A
Address
Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Qilian International Holding Group (Qilian International Holding Group) Headlines

From GuruFocus